Big Pharma CEO Panics over Bernie Sanders’ Medicare-For-All Plan

Senator Bernie Sanders is unveiling a “Medicare-for-all” health care bill on Capitol Hill Wednesday, and the growing support for a single-payer system has pharmaceutical CEOs worried.

Brent Saunders, chief executive of Allergan, expressed concern last week during a conference sponsored by Wells Fargo that Americans could grow tired of the politicization of their health care needs. Sanders’ single-payer plan would earn widespread support if the pharmaceutical and health care giants didn’t win back public trust.

“Because ultimately, someone’s going to be in the White House. Somebody’s going to be in Congress,” Saunders said during the conference. “Someone’s going to be somewhere and going to have to say, ‘Enough’s enough. Let’s just change the whole system. Let’s go to one payer. Let’s do something.'”

Yes, big pharma and health-care corporations are worried that Americans will begin to push back against a system that prioritizes profit over affordable care.

Saunders isn’t wrong about the lack of trust in drug companies. He correctly noted that the industry scores poorly in public trust surveys, sometimes placing lower than the tobacco and oil industries.

Saunders’ sentiment is not surprising either, considering that many leaders of large corporations do not support single payer. Instead, they prefer to shift more burden on employees by providing plans with higher and higher deductibles, for example.

Meanwhile, many high-profile Democrats are lining up behind Sanders’ bill, and polls show increasing public support for such a proposal — something that would have been unthinkable only a few years ago.